Cargando…
Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710264/ https://www.ncbi.nlm.nih.gov/pubmed/28494075 http://dx.doi.org/10.1001/jamaophthalmol.2017.1109 |
_version_ | 1783282927130378240 |
---|---|
author | Bastawrous, Andrew Mathenge, Wanjiku Peto, Tunde Shah, Nisha Wing, Kevin Rono, Hillary Weiss, Helen A. Macleod, David Foster, Allen Burton, Matthew Kuper, Hannah |
author_facet | Bastawrous, Andrew Mathenge, Wanjiku Peto, Tunde Shah, Nisha Wing, Kevin Rono, Hillary Weiss, Helen A. Macleod, David Foster, Allen Burton, Matthew Kuper, Hannah |
author_sort | Bastawrous, Andrew |
collection | PubMed |
description | IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort with 6-year follow-up of 4414 participants who had a complete assessment. Random cluster sampling with probability proportionate to size procedures was used to select a representative, cross-sectional sample of adults 50 years and older from January 26, 2007, through November 11, 2008. A 6-year follow-up was undertaken from January 7, 2013, through March 12, 2014. On both occasions, a comprehensive ophthalmic examination was performed that included logMAR visual acuity, digital retinal photography, and grading of images at Moorfields Eye Hospital Reading Centre. Data were collected on general health and risk factors. MAIN OUTCOMES AND MEASURES: Incident AMD in participants with no AMD at baseline and progression from early to late AMD. RESULTS: A total of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuyu [62.3%], 324 Kalenjin [25.3%], and 159 other [12.4%]); 1282 had data on AMD status at follow-up. Of these, 202 developed early AMD, and no participants developed late AMD. The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 persons (95% CI, 136.7-195.9 per 1000 persons). Two individuals with baseline early AMD from the 142 at risk had developed late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late AMD of 24.5 per 1000 persons (95% CI, 5.0-111.7 per 1000 persons). Cumulative incidence of AMD increased with age (≥80 years old vs 50-59 years old: 1.8; 95% CI, 0.9-3.5) and was higher in women (female vs male: 1.6; 95% CI, 1.2-2.1) and persons with diabetes (diabetes vs no diabetes: 1.7; 95% CI, 1.0-2.8). CONCLUSIONS AND RELEVANCE: In Kenya, more than 100 000 estimated new cases of AMD, mainly early AMD, will develop every year in individuals 50 years or older, although a 50% loss to follow-up and wide CIs for progression to late AMD limit definitive conclusions from these findings. |
format | Online Article Text |
id | pubmed-5710264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-57102642017-12-06 Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study Bastawrous, Andrew Mathenge, Wanjiku Peto, Tunde Shah, Nisha Wing, Kevin Rono, Hillary Weiss, Helen A. Macleod, David Foster, Allen Burton, Matthew Kuper, Hannah JAMA Ophthalmol Original Investigation IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort with 6-year follow-up of 4414 participants who had a complete assessment. Random cluster sampling with probability proportionate to size procedures was used to select a representative, cross-sectional sample of adults 50 years and older from January 26, 2007, through November 11, 2008. A 6-year follow-up was undertaken from January 7, 2013, through March 12, 2014. On both occasions, a comprehensive ophthalmic examination was performed that included logMAR visual acuity, digital retinal photography, and grading of images at Moorfields Eye Hospital Reading Centre. Data were collected on general health and risk factors. MAIN OUTCOMES AND MEASURES: Incident AMD in participants with no AMD at baseline and progression from early to late AMD. RESULTS: A total of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuyu [62.3%], 324 Kalenjin [25.3%], and 159 other [12.4%]); 1282 had data on AMD status at follow-up. Of these, 202 developed early AMD, and no participants developed late AMD. The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 persons (95% CI, 136.7-195.9 per 1000 persons). Two individuals with baseline early AMD from the 142 at risk had developed late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late AMD of 24.5 per 1000 persons (95% CI, 5.0-111.7 per 1000 persons). Cumulative incidence of AMD increased with age (≥80 years old vs 50-59 years old: 1.8; 95% CI, 0.9-3.5) and was higher in women (female vs male: 1.6; 95% CI, 1.2-2.1) and persons with diabetes (diabetes vs no diabetes: 1.7; 95% CI, 1.0-2.8). CONCLUSIONS AND RELEVANCE: In Kenya, more than 100 000 estimated new cases of AMD, mainly early AMD, will develop every year in individuals 50 years or older, although a 50% loss to follow-up and wide CIs for progression to late AMD limit definitive conclusions from these findings. American Medical Association 2017-06-08 2017-06 /pmc/articles/PMC5710264/ /pubmed/28494075 http://dx.doi.org/10.1001/jamaophthalmol.2017.1109 Text en Copyright 2017 Bastawrous A et al. JAMA Ophthalmology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Bastawrous, Andrew Mathenge, Wanjiku Peto, Tunde Shah, Nisha Wing, Kevin Rono, Hillary Weiss, Helen A. Macleod, David Foster, Allen Burton, Matthew Kuper, Hannah Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title_full | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title_fullStr | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title_full_unstemmed | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title_short | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study |
title_sort | six-year incidence and progression of age-related macular degeneration in kenya: nakuru eye disease cohort study |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710264/ https://www.ncbi.nlm.nih.gov/pubmed/28494075 http://dx.doi.org/10.1001/jamaophthalmol.2017.1109 |
work_keys_str_mv | AT bastawrousandrew sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT mathengewanjiku sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT petotunde sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT shahnisha sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT wingkevin sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT ronohillary sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT weisshelena sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT macleoddavid sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT fosterallen sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT burtonmatthew sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy AT kuperhannah sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy |